Schroeder Shannon M, Matsukuma Karen E, Medici Valentina
Department of Internal Medicine, University of California Davis, Sacramento, CA, USA.
Department of Pathology and Laboratory Medicine, University of California Davis, Sacramento, CA, USA.
Ann Transl Med. 2021 Sep;9(17):1394. doi: 10.21037/atm-21-2264.
The goal of the present work is to provide an overview of the differential diagnosis of Wilson disease.
Wilson disease is a rare condition due to copper accumulation primarily in the liver and brain. Although there is no definitive cure, current anti-copper treatments are associated with better outcomes if initiated early and if the diagnosis is made promptly. However, diagnostic delays are frequent and often Wilson disease represents a diagnostic challenge. The diagnosis ultimately relies on a combination of clinical, laboratory and genetic findings, and it is crucial that clinicians list Wilson disease in their differential diagnosis, especially in patients presenting with a hepatocellular pattern of liver injury. Some biochemical and liver histological features of Wilson disease overlap with those of more common conditions including nonalcoholic fatty liver disease, alcohol-associated liver disease, and autoimmune hepatitis. In particular, hepatic steatosis, hepatocyte glycogenated nuclei, ballooning degeneration, and Mallory-Denk bodies are often identified in Wilson disease as well as more common liver diseases. In addition, the natural history of liver damage in Wilson disease and the risk of developing liver cancer are largely understudied.
We conducted an enlarged review of published papers on Wilson disease focusing on its diagnosis and distinctive clinical and liver pathology features in relation to common non-cholestatic liver diseases with the final goal in aiding clinicians in the diagnostic process of this rare but treatable condition.
Aside from markedly altered copper metabolism, Wilson disease has essentially no pathognomonic features that can distinguish it from more common liver diseases. Clinicians should be aware of this challenge and consider Wilson disease in patients presenting with a hepatocellular pattern of liver injury.
本研究旨在概述肝豆状核变性的鉴别诊断。
肝豆状核变性是一种罕见疾病,主要由于铜在肝脏和大脑中蓄积所致。尽管尚无根治方法,但如果早期开始并及时诊断,目前的抗铜治疗可带来更好的治疗效果。然而,诊断延迟很常见,肝豆状核变性常常是一个诊断难题。最终诊断依赖于临床、实验室和基因检查结果的综合判断,临床医生在鉴别诊断中列出肝豆状核变性至关重要,尤其是对于出现肝细胞性肝损伤模式的患者。肝豆状核变性的一些生化和肝脏组织学特征与包括非酒精性脂肪性肝病、酒精性肝病和自身免疫性肝炎等更常见疾病的特征重叠。特别是,肝脂肪变性、肝细胞糖原核、气球样变性和马洛里-登克小体在肝豆状核变性以及更常见的肝脏疾病中都经常被发现。此外,肝豆状核变性中肝损伤的自然史以及发生肝癌的风险在很大程度上尚未得到充分研究。
我们对已发表的关于肝豆状核变性的论文进行了扩展综述,重点关注其诊断以及与常见非胆汁淤积性肝病相关的独特临床和肝脏病理学特征,最终目的是帮助临床医生诊断这种罕见但可治疗的疾病。
除了铜代谢明显改变外,肝豆状核变性基本上没有能够将其与更常见肝脏疾病区分开来的特征性表现。临床医生应意识到这一挑战,并在出现肝细胞性肝损伤模式的患者中考虑肝豆状核变性。